It says a lot about the expectations of holders that a hazard ratio the same as Herceptin - which has annual sales above 3 times the market cap of IMU - is considered mediocre, DESPITE the fact that HER-Vaxx has lower toxicity and is only one of the company's platforms to boot!
Yes it's not as good as the previous trial, but it's still an excellent, excellent result.
It says a lot about the expectations of holders that a hazard...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $396.8M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.3¢ | $537.6K | 10.00M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 207796 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 1452903 | 6 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |